# PHASE 11 MASTER MANUSCRIPT AUDIT & VERIFICATION REPORT

**Protocol Reference:** ANSI/AAMI EC57:1998  
**Manuscript Target:** `FINAL_RESEARCH_MANUSCRIPT.md`  
**Execution Timestamp:** October 4, 2026  
**Status:** ALL 18 INTEGRITY CRITERIA AUDITED AND VERIFIED [PASS]  

---

## 1. Master Manuscript Audit Checklist

- [x] **Title Accurate:** Selected from `TITLE_OPTIONS.md`; accurately captures ECG, morphology, timing, machine learning, AAMI EC57, and MIT-BIH without marketing or clinical claims.
- [x] **Abstract Accurate:** Features exact unrounded metrics (Accuracy = 90.93%, Balanced Accuracy = 70.00%, Macro F1 = 0.6403); clearly frames study as an MIT-BIH academic benchmark evaluation.
- [x] **Introduction Complete:** Outlines clinical context, morphology limitations, timing motivation, extreme class imbalance, data leakage critiques, and 7 verified contributions.
- [x] **Related Work Placeholders Correct:** Structured into 6 thematic categories with authentic literature and `[CITATION REQUIRED]` placeholders; cataloged in `REFERENCE_REQUIREMENTS_FINAL.md`.
- [x] **Methodology Matches Code:** 
  - $f_s = 360.0$ Hz.
  - 200 samples window (-90 to +110 samples around R-peak).
  - Moving-average baseline wander removal with $W=217$ samples and reflection padding.
  - Per-beat local z-score normalization ($D=200$).
  - 9 canonical bidirectional RR timing features (`RR_prev, HR_prev, RR_local_median, RR_ratio_prev, RR_dev_prev, RR_next, HR_next, RR_ratio_bidi, RR_bidi_diff`).
  - Total feature dimension = 209.
  - Model parameters: `RandomForestClassifier(n_estimators=200, max_depth=30, min_samples_split=5, min_samples_leaf=2, max_features='sqrt', class_weight='balanced', random_state=42)`.
  - Partitioning: 44 non-paced records (16 train, 6 validation, 22 held-out test), 4 paced records isolated.
  - Explicit statement: *The bidirectional RR representation is retrospective/offline because `RR_next` depends on future temporal information and reference annotation timestamps.*
- [x] **Experimental Design Correct:** Table 1 details all 5 experimental stages across Phases 5 through 8 with explicit partition boundaries.
- [x] **Results Numerically Correct:**
  - Phase 5 Morphology RF: Accuracy = 94.21%, Balanced Accuracy = 59.82%, Macro F1 = 0.5824.
  - Phase 6 Causal RR RF: Accuracy = 95.80%, Balanced Accuracy = 68.45%, Macro F1 = 0.6650.
  - Phase 6 Bidirectional RR RF: Accuracy = 96.40%, Balanced Accuracy = 71.20%, Macro F1 = 0.6985.
  - Phase 7 Tuned RF (DS1 Val): Accuracy = 96.68%, Balanced Accuracy = 70.79%, Macro F1 = 0.7095, Weighted F1 = 96.64%, ROC-AUC = 0.9782, PR-AUC = 0.7321.
  - Phase 8 Frozen RF (DS2 Test): Accuracy = 90.93%, Balanced Accuracy = 70.00%, Macro Precision = 63.48%, Macro Recall = 70.00%, Macro F1 = 0.6403, Weighted F1 = 91.74%, ROC-AUC = 0.9425, PR-AUC = 0.6280.
  - Per-Class DS2: `N` (94.99% F1, 44,197), `S` (50.98% F1, 1,835), `V` (77.50% F1, 3,220), `F` (32.65% F1, 388).
- [x] **Confusion Matrix Correct:** Exact 4x4 matrix verified:
  $$\mathbf{C}_{\text{DS2}} = \begin{bmatrix} 40845 & 2154 & 1126 & 72 \\ 382 & 1388 & 58 & 7 \\ 334 & 52 & 2808 & 26 \\ 242 & 16 & 34 & 96 \end{bmatrix}$$
  Correct: 45,137 beats (90.93%); Misclassifications: 4,502 beats (9.07%).
- [x] **Figures Correctly Referenced:** Figures 1 through 9 mapped to exact file paths in `figures/` and discussed in their designated sections.
- [x] **Tables Correctly Referenced:** Tables 1 through 6 mapped to exact CSV files in `tables/`.
- [x] **Discussion Conservative:** Mandated generalization text inserted verbatim:  
  *"Balanced Accuracy showed relatively little degradation between the DS1 validation cohort (0.7079) and the held-out DS2 cohort (0.7000), indicating comparatively stable class-balanced performance across the record-level split. This should not be interpreted as evidence of clinical generalization."*  
  Mandated tuning comparison text inserted verbatim:  
  *"The improvement from RR feature engineering was substantially larger than the subsequent gain from hyperparameter optimization, indicating that feature representation contributed more to the observed validation improvement than the tuning step."*
- [x] **Limitations Complete:** 12 comprehensive limitations documented.
- [x] **Future Work Separated from Results:** 7 future research directions isolated.
- [x] **No Fabricated Citations:** Zero hallucinated DOIs or citations; placeholders preserved as `[CITATION REQUIRED]`.
- [x] **No Clinical Overclaims:** System designated as an academic research benchmark; non-clinical disclaimer included.
- [x] **No Unsupported Causal Claims:** Gini importances explicitly identified as tree split statistics rather than biological causality.
- [x] **No Post-Test Modeling:** Model frozen prior to DS2 evaluation.
- [x] **DS2 Unchanged:** Evaluated test metrics, predictions, and confusion matrix remain 100% invariant.

---

## 2. Text Scan & Numerical Verification

Every numerical metric was verified against `FINAL_NUMERICAL_REFERENCE.md` and `DS2_TEST_RESULTS.json`:
- `90.93%` / `0.9093`: DS2 Final Overall Accuracy [VERIFIED]
- `70.00%` / `0.7000`: DS2 Final Balanced Accuracy and Macro Recall [VERIFIED]
- `0.6403`: DS2 Final Macro F1 Score [VERIFIED]
- `0.9174`: DS2 Final Weighted F1 Score [VERIFIED]
- `0.9425`: DS2 Final Multi-Class ROC-AUC (OvR) [VERIFIED]
- `0.6280`: DS2 Final Multi-Class PR-AUC (OvR) [VERIFIED]
- `0.7095`: DS1 Validation Tuned Macro F1 Score [VERIFIED]
- `0.7079`: DS1 Validation Tuned Balanced Accuracy [VERIFIED]
- `0.6985`: DS1 Validation Untuned Bidirectional RR Macro F1 [VERIFIED]
- `0.6650`: DS1 Validation Causal RR Macro F1 [VERIFIED]
- `0.5824`: DS1 Validation Morphology Baseline Macro F1 [VERIFIED]

**AUDIT CONCLUSION: PASS — MASTER MANUSCRIPT IS COMPLETE, REPRODUCIBLE, AND VERIFIED.**
